Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-6,443
Closed -$376K 2158
2025
Q1
$376K Sell
6,443
-1,432
-18% -$78.8K ﹤0.01% 1557
2024
Q4
$414K Buy
7,875
+5,095
+183% +$296K ﹤0.01% 1600
2024
Q3
$160K Sell
2,780
-692
-20% -$40.4K ﹤0.01% 1701
2024
Q2
$179K Sell
3,472
-518
-13% -$26.6K ﹤0.01% 1596
2024
Q1
$196K Buy
3,990
+827
+26% +$41.6K ﹤0.01% 1639
2023
Q4
$164K Buy
3,163
+1,178
+59% +$57K ﹤0.01% 1679
2023
Q3
$90.2K Hold
1,985
﹤0.01% 1776
2023
Q2
$101K Buy
+1,985
New +$110K ﹤0.01% 1769

Other funds holding UTL

Amundi's UTL Position: Q2 2025 in Review

Amundi sold out of Unitil (UTL) in Q2 2025, closing a stake of 6,443 shares — an estimated $376K sold.

Amundi first reported a position in UTL in Q2 2023 and held it in 8 quarters. The position peaked at $414K in Q4 2024. 220 funds tracked by Wall St. Rank hold UTL as of Q2 2025.

  • Amundi reported no remaining Unitil position as of Q2 2025 after selling out during the quarter.
  • Amundi sold 6,443 Unitil shares in Q2 2025, an estimated $376K.
  • Amundi first reported a position in Unitil in Q2 2023 and held it in 8 quarters.
  • Amundi's Unitil position peaked at $414K in Q4 2024.
  • 220 funds tracked by Wall St. Rank held Unitil as of Q2 2025.

Based on Amundi's 13F filing for Q2 2025, filed 13 Aug 2025.